Fetal hydrops and anemia as signs of Down syndrome

Journal of the Formosan Medical Association

Volumn 110, Issue 11, 2011, Pages 716-718

  Şükür, Yavuz Emre ^a   Gözüküçük, Murat ^a   Bayramov, Vugar ^a   Koç, Acar ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Down syndrome; Fetal hydrops; Myelopoiesis; Pancytopenia

Indexed keywords

DIGOXIN;

ADULT; ANEMIA; ARTICLE; CASE REPORT; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CORDOCENTESIS; DOWN SYNDROME; DRUG BLOOD LEVEL; FEMALE; FETUS HYDROPS; GESTATIONAL AGE; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; INTRAUTERINE GROWTH RETARDATION; KARYOTYPE; PANCYTOPENIA; SUPRAVENTRICULAR TACHYCARDIA;

ADULT; ANEMIA; DOWN SYNDROME; FEMALE; FETAL DISEASES; HUMANS; HYDROPS FETALIS; PREGNANCY;

EID: 82255179268     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2011.09.009     Document Type: Article

References (18)

1. Heinonen S., Ryynanen M., Kirkinen P. Etiology and outcome of second trimester non-immunologic fetal hydrops. Acta Obstet Gynecol Scand 2000, 79:15-18.
2. Machim G.A. Hydrops revisited: literature review of 1414 cases published in the 1980s. Am J Med Genet 1989, 34:366-390.
3. Leslie A.P. Hydrops fetalis. Newborn Infant Nursing Rev 2006, 6:e1-e8.
4. Rose C.H., Bofill J.A., Le M., Martn R.W. Non-immune hydrops fetalis: prenatal diagnosis and perinatal outcomes. J Miss State Med Assoc 2005, 46:99-102.
5. Maayan-Metzger A., Sack J., Mazkereth R., Vardi A., Kuint J. Somatostatin treatment of congenital chylothorax may induce transient hypothyroidism in newborns. J Korean Med Sci 2005, 94:785-789.
6. Maeno Y., Himeno W., Saito A. Clinical course of fetal congenital atrioventricular block in the Japanese population: a multicentre population. Heart 2005, 91:1075-1079.
7. Jauniaux E. Diagnosis and management of early non-immune hydrops fetalis. Prenat Diagn 1997, 17:1261-1268.
8. Xu J., Raff T.C., Muallem N.S., Neubert A.G. Hydrops fetalis secondary to parvovirus B19 infections. J Am Board Fam Pract 2003, 16:63-68.
9. Robertson M., De Jong G., Mansvelt E. Prenatal diagnosis of congenital leukemia in a fetus at 25 weeks gestation with Down syndrome: case report and review of the literature. Ultrasound Obstet Gynecol 2003, 21:486-489.
10. Benacerraf B.R. The role of the second trimester genetic sonogram in screening for fetal Down syndrome. Semin Perinatol 2005, 29:386-394.
11. Zipursky A., Brown F.J., Christensen H., Doyle J. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Clin Lab Med 1999, 19:157-167.
12. Hojo S., Tsukimori K., Kitade S., Nakanami N., Hikino S., Hara T., et al. Prenatal sonographic findings and hematological abnormalities in fetuses with transient abnormal myelopoesis with down syndrome. Prenat Diagn 2007, 27:507-511.
13. Baschat A.A., Wagner T., Malisius R., Gembruch U. Prenatal diagnosis of a transient myeloproliferative disorder in trisomy 21. Prenat Diagn 1998, 18:731-736.
14. Ochiai M., Hikino S., Nakayama H., Ohga S., Taguchi T., Hara T. Nonimmune hydrops fetalis due to generalized lymphatic dysplasia in an infant with robertsonian trisomy 21. Am J Perinatol 2006, 23:63-66.
15. Swain S., Cameron A.D., McNay M.B., Howatson A.G. Prenatal diagnosis and management of nonimmune hydrops fetalis. Aust NZ J Obstet Gynaecol 1999, 39:285-290.
16. Bukowski R., Saade G.R. Hydrops fetalis. Clin Perinatol 2000, 27:1007-1031.
17. Moise K. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 2002, 100:600-611.
18. van Kamp I.L., Klumper F.J., Oepkes D., Meerman R.H., Scherjon S.A., Vandenbussche F.P., et al. Complications of intravascular intrauterine transfusion for fetal anemia due to maternal red cell alloimmunization. Am J Obstet Gynecol 2005, 192:171-177.